by Heinz Meissner
Download Research and development priorities of the dairy industry 2026-2029
Click on any of the publications below to read more about the specific topic:
admin@milksa.co.za
012 460 7312
Brooklyn Court, Block B, First floor,
361 Veale Street, Nieuw Muckleneuk
Pretoria, South Africa
Download Research and development priorities of the dairy industry 2026-2029
Click on any of the publications below to read more about the specific topic:
| Title | Date | Discipline | Extract | Keywords |
|---|---|---|---|---|
| MASTITIS RESEARCH IN SA: AMR AND TREATMENT. | Antimicrobial resistance (AMR): The results of an antibiotic susceptibility testing trial of Staph. aureus isolates showed that 75-80% isolates were multidrug resistant. The isolates were found to be 100% resistant to amoxicillin, ampicillin and penicillin G, 95% resistant to cephalexin, 82% resistant to streptomycin, 75% resistant to oxacillin, 64% resistant to erythromycin, 50% resistant to tobramycin, 46% resistant to tetracycline and 39% resistant to vancomycin. None of the Staph. |
|||
| BIOFILM FORMATION AND ANTIMICROBIAL RESISTANCE PATTERNS OF STREPTOCOCCUS UBERIS SPECIES. | Antimicrobial resistance (AMR) is a global threat to human and veterinary medicine. Often it is not known to which antimicrobials specific mastitis-causing pathogens such as Streptococcus uberis are resistant or to which new antimicrobials they are sensitive to. A complicating factor is that one of the resistance strategies of many pathogens which makes it more difficult to treat than their planktonic counterparts, is biofilm formation. A further complicating issue is that virulence factors of Str. |